BNO 5.26% 20.0¢ bionomics limited

there's a complete disconnect between the science and the...

  1. 590 Posts.
    lightbulb Created with Sketch. 4

    there's a complete disconnect between the science and the business. The board seem completely uninterested in shareholder engagement. This isn't new. It has been a persistent problem with this company.


    It's completely unacceptable the zero communications since the failed PTSD results. They have given shareholders no indication what their direction or objectives are short or long term. The company currently has no narrative. There is no reason for people to be supporting the share price.


    I don't think there are really any questions around the science. But Deborah Rathjen is CEO - taking home half a mill a year and she hasn't provided a way forward, At best she has left the future of 210 as murky - it's their biggest asset. My opinion is that she isn't doing her job, my opinion is that she should step down. She had the opportunity 5 years ago to address the company's problems with shareholder engagement and she swept it under the rug.


     Round number support means we could be at 15 for a while. But it looks like it's down to $0.11 from there.


    I don't give her much of a chance at the AGM. I've said it before but I have a feeling that we will see further reductions in the share price day of or soon after the AGM.



 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.